We’re proud to see Ear Science Institute Australia represented on the global stage this month, with Postdoctoral Research Associate Christine Bacal attending the Controlled Release Society (CRS) 2026 Annual Meeting & Exposition in Lisbon, Portugal.
Christine will present her work, “Advanced Charge-Switching Silk Films Enable Precise Long-Lasting, Multi-Drug Delivery Control,” showcasing the depth and innovation of Ear Science’s research in therapeutic delivery.
As one of the leading international forums for delivery science, the CRS Annual Meeting brings together world experts across research, clinical practice, industry, and regulation. This year’s theme, “Multisector Innovation for Advancing Delivery Science,” highlights the evolving technologies shaping the future of treatment — from discovery through to clinical application.
Our participation reflects Ear Science’s commitment to world-class research and its growing contribution to global conversations in advanced drug delivery. It also provides an important platform to connect with other international leaders driving innovation in the field.
